Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' RIVIER J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Reyes, TM; Lewis, K; Perrin, MH; Kunitake, KS; Vaughan, J; Arias, CA; Hogenesch, JB; Gulyas, J; Rivier, J; Vale, WW; Sawchenko, PE
      Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    2. Lewis, K; Li, C; Perrin, MH; Blount, A; Kunitake, K; Donaldson, C; Vaughan, J; Reyes, TM; Gulyas, J; Fischer, W; Bilezikjian, L; Rivier, J; Sawchenko, PE; Vale, WW
      Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Mullins, D; Kirby, D; Hwa, J; Guzzi, M; Rivier, J; Parker, E
      Identification of potent and selective neuropeptide YY1 receptor agonists with orexigenic activity in vivo

      MOLECULAR PHARMACOLOGY
    4. Currie, PJ; Coscina, DV; Bishop, C; Coiro, CD; Koob, GF; Rivier, J; Vale, W
      Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient

      BRAIN RESEARCH
    5. Spina, MG; Basso, AM; Zorrilla, EP; Heyser, CJ; Rivier, J; Vale, W; Merlo-Pich, E; Koob, GF
      Behavioral effects of central administration of the novel CRF antagonist astressin in rats

      NEUROPSYCHOPHARMACOLOGY
    6. Albers, AR; O'Dorisio, MS; Balster, DA; Caprara, M; Gosh, P; Chen, F; Hoeger, C; Rivier, J; Wenger, GD; O'Dorisio, TM; Qualman, SJ
      Somatostatin receptor gene expression in neuroblastoma

      REGULATORY PEPTIDES
    7. Weisinger, RS; Blair-West, JR; Burns, P; Denton, DA; McKinley, MJ; Purcell, B; Vale, W; Rivier, J; Sunagawa, K
      The inhibitory effect of hormones associated with stress on Na appetite ofsheep

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Reubi, JC; Schaer, JC; Wenger, S; Hoeger, C; Erchegyi, J; Waser, B; Rivier, J
      SST3-selective potent peptidic somatostatin receptor antagonists

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    9. Martinez, V; Rivier, J; Coy, D; Tache, Y
      Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Sypniewski, M; Penke, B; Simon, L; Rivier, J
      (R)-tert-butoxycarbonylamino-fluorenylmethoxycarbonyl-glycine from (S)-benzyloxycarbonyl-serine or from papain resolution of the corresponding amide or methyl ester

      JOURNAL OF ORGANIC CHEMISTRY
    11. Nozu, T; Martinez, V; Rivier, J; Tache, Y
      Peripheral urocortin delays gastric emptying: role of CRF receptor 2

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    12. Martinez, V; Rivier, J; Tache, Y
      Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. Cervini, L; Theobald, P; Corrigan, A; Craig, AG; Rivier, C; Vale, W; Rivier, J
      Corticotropin releasing factor (CRF) agonists with reduced amide bonds andSer(7) substitutions

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Chen, LC; Hoeger, C; Rivier, J; Fitzpatrick, VD; Vandlen, RL; Tashjian, AH
      Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    15. Basso, AM; Spina, M; Rivier, J; Vale, W; Koob, GF
      Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like"effect in the defensive burying paradigm but not in the elevated plus-mazefollowing chronic cocaine in rats

      PSYCHOPHARMACOLOGY
    16. MILLER C; RIVIER J
      ANALYSIS OF SYNTHETIC PEPTIDES BY CAPILLARY-ZONE-ELECTROPHORESIS IN ORGANIC AQUEOUS BUFFERS/

      The journal of peptide research
    17. ANDO T; RIVIER J; YANAIHARA H; ARIMURA A
      PERIPHERAL CORTICOTROPIN-RELEASING FACTOR MEDIATES THE ELEVATION OF PLASMA IL-6 BY IMMOBILIZATION STRESS IN RATS

      American journal of physiology. Regulatory, integrative and comparative physiology
    18. MARTINEZ V; BARQUIST E; RIVIER J; TACHE Y
      CENTRAL CRF INHIBITS GASTRIC-EMPTYING OF A NUTRIENT SOLID MEAL IN RATS - THE ROLE OF CRF2 RECEPTORS

      American journal of physiology: Gastrointestinal and liver physiology
    19. ENGLAND LJ; IMPERIAL J; JACOBSEN R; CRAIG AG; GULYAS J; AKHTAR M; RIVIER J; JULIUS D; OLIVERA BM
      INACTIVATION OF A SEROTONIN-GATED ION-CHANNEL BY A POLYPEPTIDE TOXIN FROM MARINE SNAILS

      Science
    20. CHAN KW; YU KL; RIVIER J; CHOW BKC
      IDENTIFICATION AND CHARACTERIZATION OF A RECEPTOR FROM GOLDFISH SPECIFIC FOR A TELEOST GROWTH HORMONE-RELEASING HORMONE-LIKE PEPTIDE

      Neuroendocrinology
    21. RIVIER J; LAHRICHI SL; GULYAS J; ERCHEGYI J; KOERBER SC; CRAIG AG; CORRIGAN A; RIVIER C; VALE W
      MINIMAL-SIZE, CONSTRAINED CORTICOTROPIN-RELEASING FACTOR AGONISTS WITH I-(I-LYS AND LYS-GLN BRIDGES(3) GLU)

      Journal of medicinal chemistry
    22. Koerber, SC; Gulyas, J; Lahrichi, SL; Corrigan, A; Craig, AG; Rivier, C; Vale, W; Rivier, J
      Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges

      JOURNAL OF MEDICINAL CHEMISTRY
    23. Rivier, J; Gulyas, J; Corrigan, A; Martinez, V; Craig, AG; Tache, Y; Vale, W; Rivier, C
      Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat

      JOURNAL OF MEDICINAL CHEMISTRY
    24. LARSEN DA; SWANSON P; DICKEY JT; RIVIER J; DICKHOFF WW
      IN-VITRO THYROTROPIN-RELEASING ACTIVITY OF CORTICOTROPIN-RELEASING HORMONE-FAMILY PEPTIDES IN COHO SALMON, ONCORHYNCHUS-KISUTCH

      General and comparative endocrinology
    25. REUBI JC; SCHAER JC; WASER B; HOEGER C; RIVIER J
      A SELECTIVE ANALOG FOR THE SOMATOSTATIN SST1-RECEPTOR SUBTYPE EXPRESSED BY HUMAN TUMORS

      European journal of pharmacology
    26. YANG H; LI WP; REEVE JR; RIVIER J; TACHE Y
      PYY-PREFERRING RECEPTOR IN THE DORSAL VAGAL COMPLEX AND ITS INVOLVEMENT IN PYY STIMULATION OF GASTRIC-ACID SECRETION IN RATS

      British Journal of Pharmacology
    27. PARKES DG; VAUGHAN J; RIVIER J; VALE W; MAY CN
      CARDIAC INOTROPIC ACTIONS OF UROCORTIN IN CONSCIOUS SHEEP

      American journal of physiology. Heart and circulatory physiology
    28. MARTINEZ V; RIVIER J; WANG LX; TACHE Y
      CENTRAL INJECTION OF A NEW CORTICOTROPIN-RELEASING FACTOR (CRF) ANTAGONIST, ASTRESSIN, BLOCKS CRF-RELATED AND STRESS-RELATED ALTERATIONS OFGASTRIC AND COLONIC MOTOR FUNCTION

      The Journal of pharmacology and experimental therapeutics
    29. MIRANDA A; LAHRICHI SL; GULYAS J; KOERBER SC; CRAIG AG; CORRIGAN A; RIVIER C; VALE W; RIVIER J
      CONSTRAINED CORTICOTROPIN-RELEASING FACTOR ANTAGONISTS WITH I-(I-LYS BRIDGES(3) GLU)

      Journal of medicinal chemistry
    30. POLIAK S; MOR F; CONLON P; WONG T; LING N; RIVIER J; VALE W; STEINMAN L
      STRESS AND AUTOIMMUNITY - THE NEUROPEPTIDES CORTICOTROPIN-RELEASING FACTOR AND UROCORTIN SUPPRESS ENCEPHALOMYELITIS VIA EFFECTS ON BOTH THEHYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND THE IMMUNE-SYSTEM

      The Journal of immunology
    31. MARTINEZ V; RIVIER J; TACHE Y
      PERIPHERAL ACTIONS OF THE NEW CRF ANTAGONIST, ASTRESSIN IN RATS

      Gastroenterology
    32. MARTINEZ V; BARQUIST E; RIVIER J; VALE W; TACHE Y
      CENTRAL CORTICOTROPIN-RELEASING FACTOR (CRF) INHIBITS GASTRIC-EMPTYING OF A SOLID MEAL VIA CRF2 RECEPTORS IN RATS

      Gastroenterology
    33. PARKER DB; POWER ME; SWANSON P; RIVIER J; SHERWOOD NM
      EXON SKIPPING IN THE GENE ENCODING PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE IN SALMON ALTERS THE EXPRESSION OF 2 HORMONES THAT STIMULATE GROWTH-HORMONE RELEASE

      Endocrinology
    34. MAECKER H; DESAI A; DASH R; RIVIER J; VALE W; SAPOLSKY R
      ASTRESSIN, A NOVEL AND POTENT CRF ANTAGONIST, IS NEUROPROTECTIVE IN THE HIPPOCAMPUS WHEN ADMINISTERED AFTER A SEIZURE

      Brain research
    35. HAN KH; HWANG KJ; KIM SM; KIM SK; GRAY WR; OLIVERA BM; RIVIER J; SHON KJ
      NMR STRUCTURE DETERMINATION OF A NOVEL CONOTOXIN, [PRO-7,13] ALPHA-A-CONOTOXIN P-IVA

      Biochemistry
    36. SHON KJ; GRILLEY M; JACOBSEN R; CARTIER GE; HOPKINS C; GRAY WR; WATKINS M; HILLYARD DR; RIVIER J; TORRES J; YOSHIKAMI D; OLIVERA BM
      A NONCOMPETITIVE PEPTIDE INHIBITOR OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR FROM CONUS-PURPURASCENS VENOM

      Biochemistry
    37. BRITTON KT; SOUTHERLAND S; VANUDEN E; KIRBY D; RIVIER J; KOOB G
      ANXIOLYTIC ACTIVITY OF NPY RECEPTOR AGONISTS IN THE CONFLICT TEST

      Psychopharmacology
    38. BARAM TZ; KOUTSOUKOS Y; SCHULTZ L; RIVIER J
      THE EFFECT OF ASTRESSIN, A NOVEL ANTAGONIST OF CORTICOTROPIN-RELEASING HORMONE (CRH), ON CRH-INDUCED SEIZURES IN THE INFANT RAT - COMPARISON WITH 2 OTHER ANTAGONISTS

      Molecular psychiatry
    39. LOWRY PJ; KOERBER SC; WOODS RJ; BAIGENT S; SUTTON S; BEHAN DP; VALE W; RIVIER J
      NATURE OF LIGAND AFFINITY AND DIMERIZATION OF CORTICOTROPIN-RELEASINGFACTOR-BINDING PROTEIN MAY BE DETECTED BY CIRCULAR-DICHROISM

      Journal of molecular endocrinology
    40. BARQUIST E; BONAZ B; MARTINEZ V; RIVIER J; ZINNER MJ; TACHE Y
      NEURONAL PATHWAYS INVOLVED IN ABDOMINAL SURGERY-INDUCED GASTRIC ILEUSIN RATS

      American journal of physiology. Regulatory, integrative and comparative physiology
    41. RIVIER J; JIANG GC; LAHRICHI SL; PORTER J; KOERBER SC; RIZO J; CORRIGAN A; GIERASCH L; HAGLER A; VALE W; RIVIER C
      DOSE RELATIONSHIP BETWEEN GNRH ANTAGONISTS AND PITUITARY SUPPRESSION

      Human reproduction
    42. KIM SM; HWANG KJ; KIM SK; SHON KJ; GRAY WR; OLIVERA BM; RIVIER J; HAN KH
      SOLUTION CONFORMATION OF [PRO 7,13]ALPHA-A-CONOTOXIN PIVA

      Progress in Biophysics and Molecular Biology
    43. SPINA M; MERLOPICH E; CHAN RKW; BASSO AM; RIVIER J; VALE W; KOOB GF
      APPETITE-SUPPRESSING EFFECTS OF UROCORTIN, A CRF-RELATED NEUROPEPTIDE

      Science
    44. LIAPAKIS G; HOEGER C; RIVIER J; REISINE T
      DEVELOPMENT OF A SELECTIVE AGONIST AT THE SOMATOSTATIN RECEPTOR SUBTYPE SSTR1

      The Journal of pharmacology and experimental therapeutics
    45. DEFONSECA FR; RUBIO P; MENZAGHI F; MERLOPICH E; RIVIER J; KOOB GF; NAVARRO M
      CORTICOTROPIN-RELEASING FACTOR (CRF) ANTAGONIST [D-PHE(12),NLE(21,38),C(ALPHA)MELEU(37)]CRF ATTENUATES THE ACUTE ACTIONS OF THE HIGHLY POTENT CANNABINOID RECEPTOR AGONIST HU-210 ON DEFENSIVE-WITHDRAWAL BEHAVIOR IN RATS

      The Journal of pharmacology and experimental therapeutics
    46. LIAPAKIS G; FITZPATRICK D; HOEGER C; RIVIER J; VANDLEN R; REISINE T
      IDENTIFICATION OF LIGAND-BINDING DETERMINANTS IN THE SOMATOSTATIN RECEPTOR SUBTYPE-1 AND SUBTYPE-2

      The Journal of biological chemistry
    47. MARTINEZ V; RIVIER J; TACHE Y
      BLOCKADE OF STRESS-RELATED ALTERATIONS OF GASTROINTESTINAL FUNCTION BY A POTENT CORTICOTROPIN-RELEASING FACTOR (CRF) ANTAGONIST - ASTRESSIN

      Gastroenterology
    48. GUE M; JUNIEN JL; REEVE JR; RIVIER J; GRANDT D; TACHE Y
      REVERSAL BY NPY, PYY AND 3-36-MOLECULAR-FORMS OF NPY AND PYY OF INTRACISTERNAL CRF-INDUCED INHIBITION OF GASTRIC-ACID SECRETION IN RATS

      British Journal of Pharmacology
    49. RIVIER C; RIVIER J; LEE S
      IMPORTANCE OF PITUITARY AND BRAIN RECEPTORS FOR CORTICOTROPIN-RELEASING FACTOR IN MODULATING ALCOHOL-INDUCED ACTH-SECRETION IN THE RAT

      Brain research
    50. RIVIER J
      UNTITLED - FOREWORD

      Biopolymers
    51. MILLER C; RIVIER J
      PEPTIDE CHEMISTRY - DEVELOPMENT OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ZONE ELECTROPHORESIS

      Biopolymers
    52. RIVIER J
      REPORT AT SCIENTIFIC CONFERENCE SCIENCE-C ONSUMING TECHNOLOGIES

      Koordinacionnaa himia
    53. VAUGHAN J; DONALDSON C; BITTENCOURT J; PERRIN MH; LEWIS K; SUTTON S; CHAN R; TURNBULL AV; LOVEJOY D; RIVIER C; RIVIER J; SAWCHENKO PE; VALE W
      UROCORTIN, A MAMMALIAN NEUROPEPTIDE RELATED TO FISH UROTENSIN-I AND TO CORTICOTROPIN-RELEASING FACTOR

      Nature
    54. GULYAS J; RIVIER C; PERRIN M; KOERBER SC; SUTTON S; CORRIGAN A; LAHRICHI SL; CRAIG AG; VALE W; RIVIER J
      POTENT, STRUCTURALLY CONSTRAINED AGONISTS AND COMPETITIVE ANTAGONISTSOF CORTICOTROPIN-RELEASING FACTOR

      Proceedings of the National Academy of Sciences of the United Statesof America
    55. HOPKINS C; GRILLEY M; MILLER C; SHON KJ; CRUZ LJ; GRAY WR; DYKERT J; RIVIER J; YOSHIKAMI D; OLIVERA BM
      A NEW FAMILY OF CONUS PEPTIDES TARGETED TO THE NICOTINIC ACETYLCHOLINE-RECEPTOR

      The Journal of biological chemistry
    56. THOMPSON KA; LAPOLT PS; RIVIER J; HENDERSON G; DAHL KD; MELDRUM DR
      GONADOTROPIN REQUIREMENTS OF THE DEVELOPING FOLLICLE

      Fertility and sterility
    57. SUTTON SW; BEHAN DP; LAHRICHI SL; KAISER R; CORRIGAN A; LOWRY P; POTTER E; PERRIN MH; RIVIER J; VALE WW
      LIGAND REQUIREMENTS OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN

      Endocrinology
    58. CAMPEN CA; LAI MT; KRAFT P; KIRCHNER T; PHILLIPS A; HAHN DW; RIVIER J
      POTENT PITUITARY-GONADAL AXIS SUPPRESSION AND EXTREMELY LOW ANAPHYLACTOID ACTIVITY OF A NEW GONADOTROPIN-RELEASING-HORMONE (GNRH) RECEPTOR ANTAGONIST AZALINE-B

      Biochemical pharmacology
    59. HALL JE; TAYLOR AE; MARTIN KA; RIVIER J; SCHOENFELD DA; CROWLEY WF
      DECREASED RELEASE OF GONADOTROPIN-RELEASING-HORMONE DURING THE PREOVULATORY MIDCYCLE LUTEINIZING-HORMONE SURGE IN NORMAL WOMEN

      Proceedings of the National Academy of Sciences of the United Statesof America
    60. MENZAGHI F; HOWARD RL; HEINRICHS SC; VALE W; RIVIER J; KOOB GF
      CHARACTERIZATION OF A NOVEL AND POTENT CORTICOTROPIN-RELEASING FACTORANTAGONIST IN RATS

      The Journal of pharmacology and experimental therapeutics
    61. CURTIS AL; GRIGORIADIS DE; PAGE ME; RIVIER J; VALENTINO RJ
      PHARMACOLOGICAL COMPARISON OF 2 CORTICOTROPIN-RELEASING FACTOR ANTAGONISTS - IN-VIVO AND IN-VITRO STUDIES

      The Journal of pharmacology and experimental therapeutics
    62. MIRANDA A; KOERBER SC; GULYAS J; LAHRICHI SL; CRAIG AG; CORRIGAN A; HAGLER A; RIVIER C; VALE W; RIVIER J
      CONFORMATIONALLY RESTRICTED COMPETITIVE ANTAGONISTS OF HUMAN RAT CORTICOTROPIN-RELEASING FACTOR/

      Journal of medicinal chemistry
    63. MELDRUM DR; RIVIER J; GARZO G; WISOT A; STUBBS C; HAMILTON F
      SUCCESSFUL PREGNANCIES WITH UNSTIMULATED CYCLE OOCYTE DONATION USING AN ANTAGONIST OF GONADOTROPIN-RELEASING-HORMONE

      Fertility and sterility
    64. HAGIWARA M; BRINDLE P; HAROOTUNIAN A; ARMSTRONG R; RIVIER J; VALE W; TSIEN R; MONTMINY MR
      COUPLING OF HORMONAL-STIMULATION AND TRANSCRIPTION VIA THE CYCLIC AMP-RESPONSIVE FACTOR CREB IS RATE LIMITED BY NUCLEAR ENTRY OF PROTEIN KINASE-A

      Molecular and cellular biology
    65. FEIFEL D; VACCARINO FJ; RIVIER J; VALE WW
      EVIDENCE FOR A COMMON NEURAL MECHANISM MEDIATING GROWTH HORMONE-RELEASING FACTOR-INDUCED AND SOMATOSTATIN-INDUCED FEEDING

      Neuroendocrinology
    66. RIVIER J; RIVIER C; GALYEAN R; MIRANDA A; MILLER C; CRAIG AG; YAMAMOTO G; BROWN M; VALE W
      SINGLE-POINT D-SUBSTITUTED CORTICOTROPIN-RELEASING FACTOR ANALOGS - EFFECTS ON POTENCY AND PHYSICOCHEMICAL CHARACTERISTICS

      Journal of medicinal chemistry
    67. HERNANDEZ JF; KORNREICH W; RIVIER C; MIRANDA A; YAMAMOTO G; ANDREWS J; TACHE Y; VALE W; RIVIER J
      SYNTHESIS AND RELATIVE POTENCIES OF NEW CONSTRAINED CRF ANTAGONISTS

      Journal of medicinal chemistry
    68. MCGRATH GA; GONCALVES RJ; UDUPA JK; GROSSMAN RI; PAVLOU SN; MOLITCH ME; RIVIER J; VALE WW; SNYDER PJ
      NEW TECHNIQUE FOR QUANTITATION OF PITUITARY-ADENOMA SIZE - USE IN EVALUATING TREATMENT OF GONADOTROPH ADENOMAS WITH A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST

      The Journal of clinical endocrinology and metabolism
    69. KETTEL LM; MURPHY AA; MORALES AJ; RIVIER J; VALE W; YEN SSC
      RAPID REGRESSION OF UTERINE LEIOMYOMAS IN RESPONSE TO DAILY ADMINISTRATION OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST

      Fertility and sterility
    70. AGUILAR MI; MOUGOS S; BOUBLIK J; RIVIER J; HEARN MTW
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF AMINO-ACIDS, PEPTIDES AND PROTEINS .128. EFFECT OF D-AMINO-ACID SUBSTITUTIONS ON THE REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY RETENTION BEHAVIOR OF NEUROPEPTIDE Y[18-36] ANALOGS

      Journal of chromatography


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 05:51:34